Drugbank Logo

Search Results

Search for "Fenofibrate" returned 6 results

Showing 1-6 out of 6
DrugBank ID Name Formula Weight
DB01039
DrugCard button for DB01039
Fenofibrate C20H21ClO4 360.8310
... urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide Humans and other mammals Ankebin Antara Elasterate Elasterin Fenobrate Fenogal Fenotard Lipanthyl ...
DB00175
DrugCard button for DB00175
Pravastatin C23H36O7 424.5277
... combination Cyclosporine Possible myopathy and rhabdomyolysis Fenofibrate Increased risk of myopathy/rhabdomyolysis Gemfibrozil Increased risk of myopathy/rhabdomyolysis Avoid alcohol. Avoid ...
DB01095
DrugCard button for DB01095
Fluvastatin C24H26FNO4 411.4659
... Dicumarol The statin increases the anticoagulant effect Fenofibrate Increased risk of myopathy/rhabdomyolysis Fluconazole Fluconazole increases the effect and toxicity of fluvastatin ...
DB00439
DrugCard button for DB00439
Cerivastatin C26H34FNO5 459.5503
... The macrolide possibly increases the statin toxicity Fenofibrate Increased risk of myopathy/rhabdomyolysis Gemfibrozil Increased risk of myopathy/rhabdomyolysis Imatinib Imatinib increases the ...
DB00227
DrugCard button for DB00227
Lovastatin C24H36O5 404.5396
... The macrolide possibly increases the statin toxicity Fenofibrate Increased risk of myopathy/rhabdomyolysis Fluconazole Increased risk of myopathy/rhabdomyolysis Fosamprenavir Amprenavir can ...
DB01076
DrugCard button for DB01076
Atorvastatin C33H35FN2O5 558.6398
... The macrolide possibly increases the statin toxicity Fenofibrate Increased risk of myopathy/rhabdomyolysis Fluconazole Increased risk of myopathy/rhabdomyolysis Fosamprenavir Amprenavir can ...
Showing 1-6 out of 6

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.